Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.
Joined September 2013
- Tweets 2,176
- Following 308
- Followers 4,471
- Likes 109
192 Photos and videos
Pinned Tweet
30 Aug 2024
TIMI is proud to celebrate our 40th anniversary! Since 1984, we've been dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease and its risk factors. View the 40th anniversary edition of the TIMI book, now online.
timi.org/40th-anniversary-ti…
1
12
64
7,177
Severe hypertriglyceridemia diabetes=↑ risk for acute pancreatitis, a potentially life-threatening condition. In a high-risk population, #olezarsen ↓ TGs by 58–65% on top of standard therapy, w/NNT of only 16 to prevent 1 pancreatitis event over 12 months #ADA26 @YumiKangEndo
1
3
236
In data from 25,090 patients from the #FOURIER trial, very low Lp(a) levels were not associated with an increased risk of most adverse safety outcomes, except a small increase in the risk of T2DM. @DrM_ODonoghue @rgiugliano
academic.oup.com/eurheartj/a…
2
9
662
Coverage in @MassGeneralNews of @NatureMedicine paper out now showing #dapagliflozin reduces risk of developing HF in genetically predisposed individuals @marstonMD
massgeneralbrigham.org/en/ab…
3
8
594
TIMI Study Group retweeted
New data from CORE-TIMI72a & CORE2-72b trials reported at #EAS2026 highlighted that #Olezarsen reduces risk of #AcutePancreatitis in people with very high #triglyceride levels.
Find out more on Triglyceride Forum…
triglycerideforum.org/meetin…
#apoC3 @AndreZimerman @TIMIStudyGroup
1
3
162
AF pts in 4 RCTs from COMBINE-AF show #DOACs had a favorable net clinical benefit over warfarin using a patient-weighted composite clinical outcome. Out now in @NEJMEvidence @rgiugliano
evidence.nejm.org/doi/10.105…
3
7
1,082
Coverage in @AMJ_Reviews of @BrianBergmark's #EuroPCR presentation on PCI vs. CABG in left main disease.
emjreviews.com/en-us/amj/int…
2
7
1,506
TIMI Study Group retweeted
May 21
One of my favorite projects at TIMI.
While exploratory, our findings support the concept that lowering LDL-C through PCSK9i may prevent the formation and progression of arterial aneurysms, including AAA.
Now in @CircAHA
@PrakritiGaba @marstonMD @BrianBergmark @TIMIStudyGroup
May 21
#Research letter: Earlier initiation of the PCSK9 inhibitor Evolocumab reduced the risk of arterial aneurysm events compared with delayed initiation in an analysis of the FOURIER trial ahajrnls.org/3PCdvbV
1
3
12
3,684
TIMI Study Group retweeted
May 29
Delighted to host Christian Ruff @TIMIStudyGroup @nyulangone for Cardioloyy Grand Rounds.
The current and future state of Factor XI inhibition for #afib
3
38
2,900
Coverage in @CardiologyToday of @BrianBergmark's EuroPCR #VESALIUS presentation #evolocumab @ebohula @rgiugliano
healio.com/news/cardiology/2…
1
5
10
850
In #VESALIUS-CV, Lp(a) was associated with risk of major coronary events and helped identify those with larger absolute benefit from #evolocumab. LBCT presentation at @EASCongress and online now at @CircAHA @rgiugliano @EBohula
ahajournals.org/doi/10.1161/…
4
15
563
Congratulations to Senior TIMI Biostatistician Andrea Bellavia, PhD, who was awarded the Teaching Citation Award from the Harvard T.H. Chan School of Public Health for excellence as a Lecturer in Biostatistics! @HarvardChanSPH
1
12
610
Similar 10-year survival following PCI vs CABG for left main disease in combined analysis of SYNTAX, PRECOMBAT, NOBLE, and EXCEL trials. @BrianBergmark #EuroPCR
1
5
444
Coverage in @TCTMD of @BrianBergmark 's #EuroPCR presentation from VESALIUS-CV (TIMI 66) #evolocumab @EBohula @rgiugliano
tctmd.com/news/evolocumab-cu…
1
9
726
In prior PCI subgroup of VESALIUS-CV trial, #evolocumab significantly reduced MACE, including 50% reduction in MI. Presented at #EuroPCR and out now in @CircAHA @BrianBergmark @EBohula @rgiugliano
ahajournals.org/doi/10.1161/…
1
2
7
741
TIMI Study Group retweeted
Vasoactive treatment in cardiogenic shock varies widely across CICUs, driven by patient-level factors and institutional practice patterns @TIMIStudyGroup @DrRobRoswell @ICUDocAP @TIMIStudyGroup ahajournals.org/doi/10.1161/…
1
11
17
1,778
TIMI Senior Investigator @DrM_ODonoghue interviewed for @TIME article on important blood tests everyone should be getting.
time.com/article/2026/05/04/…
3
18
799
1
6
520
Listen again to the TIMI Talks podcast episode with legendary cardiologist and TIMI Study Group founder Dr. Eugene Braunwald, where he discussed his illustrious career and the beginnings of TIMI. @ddbergMD
timi.org/2023/04/14/timi-tal…
6
19
1,053
Eugene Braunwald, ‘Icon’ of Modern Cardiology, Dies at 96 tctmd.com/news/eugene-braunw…
8
22
1,341
We are deeply saddened to have lost our founding chairman and the father of modern academic cardiology, Dr. Eugene Braunwald, who founded the TIMI Study Group in 1984, and with that vision profoundly shaped the practice of cardiovascular medicine across the world.
4
71
226
8,709
More than 40 years, 80 clinical trials, and 450,000 trial participants later, we are proud that the TIMI Study Group has impacted almost every facet of cardiovascular care. Dr. Braunwald’s intellectual rigor and zeal for discovery were legendary.
1
2
29
909
While he touched many lives, we at TIMI were truly blessed to directly work with and learn from him over treasured decades. We will deeply miss him, but take comfort in knowing that we will carry forward his legacy and continue his lifelong mission to advance cardiovascular care.
3
28
755